Relaxin family peptides: structure-activity relationship studies

被引:70
作者
Patil, Nitin A. [1 ,2 ]
Rosengren, K. Johan [3 ]
Separovic, Frances [2 ]
Wade, John D. [1 ,2 ]
Bathgate, Ross A. D. [1 ,3 ]
Hossain, Mohammed Akhter [1 ,2 ]
机构
[1] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia
[2] Univ Melbourne, Sch Chem, Parkville, Vic, Australia
[3] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic, Australia
基金
澳大利亚研究理事会; 英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
D O I
10.1111/bph.13684
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The human relaxin peptide family consists of seven cystine-rich peptides, four of which are known to signal through relaxin family peptide receptors, RXFP1-4. As these peptides play a vital role physiologically and in various diseases, they are of considerable importance for drug discovery and development. Detailed structure-activity relationship (SAR) studies towards understanding the role of important residues in each of these peptides have been reported over the years and utilized for the design of antagonists and minimized agonist variants. This review summarizes the current knowledge of the SAR of human relaxin 2 (H2 relaxin), human relaxin 3 (H3 relaxin), human insulin-like peptide 3 (INSL3) and human insulin-like peptide 5 (INSL5).
引用
收藏
页码:950 / 961
页数:12
相关论文
共 50 条
  • [21] Structure-activity studies of SchistoFLRFamide-like peptides
    Lange, AB
    Orchard, I
    Wang, Z
    Starratt, AN
    Nachman, RJ
    NEUROPEPTIDES IN DEVELOPMENT AND AGING, 1997, 814 : 305 - 306
  • [22] Structure-activity relationship studies of curcumin analogues
    Fuchs, James R.
    Pandit, Bulbul
    Bhasin, Deepak
    Etter, Jonathan P.
    Regan, Nicholas
    Abdelhamid, Dalia
    Li, Chenglong
    Lin, Jiayuh
    Li, Pui-Kai
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (07) : 2065 - 2069
  • [23] Structure-activity relationship studies of gymnocin-A
    Tsukano, Chihiro
    Sasaki, Makoto
    TETRAHEDRON LETTERS, 2006, 47 (38) : 6803 - 6807
  • [24] STRUCTURE-ACTIVITY RELATIONSHIP OF NATURAL AND SYNTHETIC OPIOTID PEPTIDES INVIVO
    DUNAIKOVACS, Z
    SZEKELY, JI
    RONAI, AZ
    MIGLECZ, E
    BAJUSZ, S
    GRAF, L
    ACTA PHYSIOLOGICA ACADEMIAE SCIENTIARUM HUNGARICAE, 1978, 52 (2-3): : 191 - 191
  • [25] Evaluation and structure-activity relationship analysis of antioxidant shrimp peptides
    Wu, Dan
    Sun, Na
    Ding, Jie
    Zhu, BeiWei
    Lin, Songyi
    FOOD & FUNCTION, 2019, 10 (09) : 5605 - 5615
  • [26] The Structure-Activity Relationship of the Antioxidant Peptides from Natural Proteins
    Zou, Tang-Bin
    He, Tai-Ping
    Li, Hua-Bin
    Tang, Huan-Wen
    Xia, En-Qin
    MOLECULES, 2016, 21 (01)
  • [27] Design of novispirin antimicrobial peptides by quantitative structure-activity relationship
    Taboureau, Olivier
    Olsen, Ole Hvilsted
    Nielsen, Jesper Duus
    Raventos, Dora
    Mygind, Per Holse
    Kristensen, Hans-Henrik
    CHEMICAL BIOLOGY & DRUG DESIGN, 2006, 68 (01) : 48 - 57
  • [28] Structure-activity relationship studies on cyclic RGD peptides utilizing novel alkene dipeptide isosteres
    Oishi, S
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2004, 124 (05): : 269 - 277
  • [29] Optimized Opioid-Neurotensin Multitarget Peptides: From Design to Structure-Activity Relationship Studies
    Gonzalez, Simon
    Dumitrascuta, Maria
    Eiselt, Emilie
    Louis, Stevany
    Kunze, Linda
    Blasiol, Annalisa
    Vivancos, Melanie
    Previti, Santo
    Dewolf, Elke
    Martin, Charlotte
    Tourwe, Dirk
    Cavelier, Florine
    Gendron, Louis
    Sarret, Philippe
    Spetea, Mariana
    Ballet, Steven
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (21) : 12929 - 12941
  • [30] Structure-activity relationship of ghrelin: Pharmacological study of ghrelin peptides
    Matsumoto, M
    Hosoda, H
    Kitajima, Y
    Morozumi, N
    Minamitake, Y
    Tanaka, S
    Matsuo, H
    Kojima, M
    Hayashi, Y
    Kangawa, K
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 287 (01) : 142 - 146